IP Library › Granted Patent US 12,365,682
Granted Patent B2
US 12,365,682 · App. 18/823,214 · Granted Jul 22, 2025

Process to make GLP1 RA and intermediates therefor

Inventors: Ayman D. Allian (Carmel, IN); Kenneth Derek Berglund (Fishers, IN); Kevin Paul Cole (Indianapolis, IN); Ashlee Jeanette Davis (Indianapolis, IN); Molly Hess (Avon, IN); Adriana Jemison (Indianapolis, IN); Mark Steven Kerr (Indianapolis, IN); Audrey Grace Mack (Indianapolis, IN); Xavier A. Ortiz-Medina (Noblesville, IN); David Michael Remick (Fishers, IN); Derek Robert Starkey (Avon, IN); Radhe Krishan Vaid (Carmel, IN); Qiang Yang (Zionsville, IN); Fumiki Kawagishi (Kanagawa, JP); Takashi Emura (Kanagawa, JP); Satoshi Tsuchiya (Kanagawa, JP); Manabu Wadamoto (Kanagawa, JP); Minoru Yamawaki (Kanagawa, JP)
Assignees: ELI LILLY AND COMPANY; CHUGAI SEIYAKU KABUSHIKI KAISHA
C07D471/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,365,682
App. No.
18/823,214
Granted
Jul 22, 2025
Kind
B2
Abstract

The present invention relates to the synthesis of 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl ]-4-methyl-6,7-dihydro-4H-pyrazolo [4,3-c] pyridine-5-carbonyl] indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one, or a salt thereof, and related synthetic intermediate compounds.

Claims (33)

1. A compound of the following structure:

2. A compound of the following structure:

wherein R is aryl, heteroaryl, alkyl, cycloalkyl, heteroalkyl, alkenyl, heteroalkenyl, alkynyl, heteroalkynyl, arylalkyl, heteroarylalkyl, arylalkenyl, heteroarylalkenyl, arylalkynyl, or heteroarylalkynyl.

3. A compound of the following structure:

4. A compound of the following structure:

5. A process for making the compound of claim 3 of the following structure:

comprising multi-step chemical reactions starting from compound 1 of the following structure:

6. The process of claim 5 , comprising multi-step chemical reactions starting from compound 1 and going through compound 5:

wherein R is aryl, heteroaryl, alkyl, cycloalkyl, heteroalkyl, alkenyl, heteroalkenyl, alkynyl, heteroalkynyl, arylalkyl, heteroarylalkyl, arylalkenyl, heteroarylalkenyl, arylalkynyl, or heteroarylalkynyl;

and arriving at compound 6.

7. The process of claim 6 , comprising a reaction step converting compound 1 to compound 2 as shown below:

wherein the reaction is carried out in a solvent selected from toluene, MTBE, THF, 2-MeTHF, DCM, EtOAc, isobutyl acetate, isopropyl acetate, dioxane, DMF, DMAc, NMP, DMI, DMSO and CPME.

8. The process of claim 7 further comprising a reaction step converting compound 2 to compound 3 as shown below in a solvent and in the presence of a catalyst:

wherein the catalyst is selected from tetrakis (triphenylphosphine) [Pd(PPh 3 ) 4 ], palladium (0), palladium chloride (PdCl 2 ), palladium (II) acetate [Pd(OAc) 2 ], allylpalladium (II) chloride dimer [PdCl(C 3 H 5 ) 2 ], Pd(dppf)Cl 2 , Pd(dtbpf)Cl 2 and a combination of two or more of the listed catalysts; and

wherein the solvent is selected from toluene, MeCN, MTBE, THF, 2-MeTHF, DCM, EtOAc, isobutyl acetate, isopropyl acetate, dioxane, DMF, DMAc, NMP, DMI, DMSO, and CPME.

9. The process of claim 8 , further comprising a reaction step converting compound 3 to compound 4 as shown below:

wherein R is aryl, heteroaryl, alkyl, cycloalkyl, heteroalkyl, alkenyl, heteroalkenyl, alkynyl, heteroalkynyl, arylalkyl, heteroarylalkyl, arylalkenyl, heteroarylalkenyl, arylalkynyl, or heteroarylalkynyl.

10. The process of claim 8 , wherein the reaction step comprises a reaction of compound 3 with CDI in a solvent, followed by a coupling with (R)-4-phenyl-2-oxazolidone in the presence of 1,8-doazabicyclo [5.4.0]undec-7-ene in a solvent.

11. The process of claim 9 , wherein the reaction step comprises a reaction of compound 3 with CDI in ACN solvent, followed by a coupling with (R)-4-benyl-2-oxazolidone in the presence of 1,8-doazabicyclo [5.4.0]undec-7-ene in N,N-dimethylacetamide solvent.

12. The process of claims 11 , further comprising a reaction step converting compound 4 to compound 5 as shown below:

wherein R is phenyl or benzyl.

13. The process of claim 12 , wherein the reaction step comprises a copper-mediated addition of 2-methyl allyl magnesium chloride, 2-methyl allyl magnesium bromide, or 2-methyl allyl magnesium iodide in the presence of lithium chloride to compound 4 to give compound 5.

14. The process of claim 13 , further comprising a reaction step converting compound 5 to compound 6 as shown below:

wherein R is phenyl or benzyl.

15. The process of claim 14 , wherein the reaction step comprises reacting compound 5 with a reducing agent in a solvent to give compound 6;

wherein the reducing agent is selected from lithium borohydride, NaBH 4 , BH3, LAH, H 2 , DIBAl, and Red-Al; and

wherein the solvent is selected from toluene, THF, 2-MeTHF, DCM, MTBE, and CPME.

16. The process of claim 15 , comprising reaction steps as shown below:

wherein R is aryl, heteroaryl, alkyl, cycloalkyl, heteroalkyl, alkenyl, heteroalkenyl, alkynyl, heteroalkynyl, arylalkyl, heteroarylalkyl, arylalkenyl, heteroarylalkenyl, arylalkynyl, or heteroarylalkynyl.

17. The process of claim 16 , further comprising multi-step chemical reactions to convert compound 6 into compound 12 having the following structure:

18. The process of claim 17 , comprising a reaction step of converting compound 6 to compound 7 as shown below:

19. The process of claim 17 , further comprising a reaction step of converting compound 10 to compound 11 as shown below:

20. The process of claim 18 , further comprising a reaction step of converting compound 10 to compound 11 as shown below:

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2025
From: EMURA, TAKASHI; KAWAGISHI, FUMIKI; TSUCHIYA, SATOSHI; WADAMOTO, MANABU; YAMAWAKI, MINORU
To: CHUGAI SEIYAKU KABUSHIKI KAISHA
Reel/Frame 071361/0519 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2024
From: ALLIAN, AYMAN D.; BERGLUND, KENNETH DEREK; COLE, KEVIN PAUL; DAVIS, ASHLEE JEANETTE; HESS, MOLLY; JEMISON, ADRIANNA; KERR, MARK STEVEN; MACK, AUDREY GRACE; ORTIZ-MEDINA, XAVIER A.; REMICK, DAVID MICHAEL; STARKEY, DEREK ROBERT; VAID, RADHE KRISHAN; YANG, QIANG
To: ELI LILLY AND COMPANY
Reel/Frame 069438/0087 →
Continuity (3)
Continuation PCTUS2023084487 · Dec 18, 2023
Provisional Application 63433515 · Dec 19, 2022
Related Publication 20250042899A1 · Feb 6, 2025
References Cited (4)
US 10858356B2 · Yoshino · 2020 [cited by examiner]
US 20190225604A1 · Yoshino et al. · 2019 [cited by applicant]
JP 2019099571 · 2019 [cited by applicant]
International Search Report and Written Opinion of PCT/US2023/084487 (filed on Dec. 18, 2023 by Eli Lilly and Company), International Search Completed on May 21, 2024, Mailed on Jun. 7, 2024 by the European Patent Offic… [cited by applicant]